10 March 2022: The Microbiology Society and Institute of Microbiology, Chinese Academy of Sciences (IMCAS) are pleased to announce their transformative agreement starting in 2022. The Publish and Read model will allow researchers at affiliated institutions to publish an unlimited number of Open Access (OA) articles in hybrid and fully OA titles, as well as having full read access to the Society’s journals portfolio.
Hua Xiang, Ph.D, Professor & Deputy Director-General, Institute of Microbiology, Chinese Academy of Sciences:
To support Institute of Microbiology, Chinese Academy of Sciences (IMCAS) authors, we are happy to have signed this publish and read agreement with the Microbiology Society. This agreement will support the open, international exchange of research in microbiology.
Peter Cotgreave, Chief Executive of the Microbiology Society:
We are very pleased to announce this agreement with Institute of Microbiology, Chinese Academy of Sciences – the largest microbiological research institution in China and historically one of the most prolific institutes worldwide choosing to publish its high quality research in our journals. This deal demonstrates the reach of the Society’s model for sustainable Open Access and its relevance internationally to academic and government institutions, facilitating Open Access for more researchers across the globe.
The number of international institutions opting into Publish and Read agreements with the Society has doubled year-on-year since its launch in 2020.
Affiliated authors with Publish and Read institutions are entitled to:
- Unlimited OA publishing: any article published in Society journals where the corresponding author is from a Publish and Read institution will be OA by default.
- Unlimited usage: any user associated with a Publish and Read institution can access the entire archive of Society content, back to 1947, for reading and for text and data mining.
Authors can check if their institution is eligible here.
Publish and Read will be across all the Society’s six journals, including hybrid titles Microbiology, Journal of General Virology, Journal of Medical Microbiology, International Journal of Systematic and Evolutionary Microbiology, and fully OA titles Access Microbiology, Microbial Genomics.
The Microbiology Society is a membership charity for scientists interested in microbes, their effects and their practical uses. It is one of the largest microbiology societies in Europe with a worldwide membership based in universities, industry, hospitals, research institutes and schools.
Our principal goal is to develop, expand and strengthen the networks available to our members so that they can generate new knowledge about microbes and ensure that it is shared with other communities. The impacts from this will drive us towards a world in which the science of microbiology provides maximum benefit to society.
Contact: Jade Heyman, Journal Sales and Transformation Manager – email@example.com
Journal's website: https://www.microbiologyresearch.org/
Institute of Microbiology, Chinese Academy of Sciences
Institute of Microbiology, Chinese Academy of Sciences (IMCAS) is the largest microbiological research institution in China. Its research areas include: Microbiology, Genetics, Biochemistry and Molecular Biology, Microbial Cell Biology, Pathogenic Microbiology, Virology, Microbial-plant Interaction, Immunology, Genome Editing, Microbiome, Microbial Ecology, Fungal Biology, Microbiomics and Bioinformatics, Synthetic Biology and Microbial Technology, Microbial Systems and Evolutionary Biology, Microbial Pharmacy, Crop-borne Diseases, Protein Engineering Technology, etc. IMCAS has developed into a comprehensive microbiological research institution with rich heritage, great strength and international reputation.
The Charlesworth Group
Microbiology Society is advised and represented in China by The Charlesworth Group. With over 20 years of experience in China, The Charlesworth Group is recognised globally as China's trusted partner for sales and marketing representation. Transformational agreements are at the heart of the accelerating shift to Open Access publishing – and we are at the forefront of taking transformative models to the market in China.